Annual Total Liabilities
$58.45 M
+$50.32 M+618.56%
31 December 2023
Summary:
Milestone Pharmaceuticals annual total liabilities is currently $58.45 million, with the most recent change of +$50.32 million (+618.56%) on 31 December 2023. During the last 3 years, it has risen by +$51.60 million (+752.74%). MIST annual total liabilities is now -59.21% below its all-time high of $143.29 million, reached on 31 December 2018.MIST Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$58.69 M
+$1.44 M+2.52%
30 September 2024
Summary:
Milestone Pharmaceuticals quarterly total liabilities is currently $58.69 million, with the most recent change of +$1.44 million (+2.52%) on 30 September 2024. Over the past year, it has increased by +$82.00 thousand (+0.14%). MIST quarterly total liabilities is now -59.04% below its all-time high of $143.29 million, reached on 31 December 2018.MIST Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIST Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +618.6% | +0.1% |
3 y3 years | +752.7% | +823.0% |
5 y5 years | -59.2% | +547.8% |
MIST Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +752.7% | at high | +1165.0% |
5 y | 5 years | -59.2% | +752.7% | at high | +1165.0% |
alltime | all time | -59.2% | +752.7% | -59.0% | +1165.0% |
Milestone Pharmaceuticals Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $58.69 M(+2.5%) |
June 2024 | - | $57.25 M(+2.1%) |
Mar 2024 | - | $56.08 M(-4.1%) |
Dec 2023 | $58.45 M(+618.6%) | $58.45 M(-0.3%) |
Sept 2023 | - | $58.61 M(+3.5%) |
June 2023 | - | $56.61 M(-0.9%) |
Mar 2023 | - | $57.15 M(+602.5%) |
Dec 2022 | $8.13 M(+12.2%) | $8.13 M(-5.6%) |
Sept 2022 | - | $8.61 M(+85.6%) |
June 2022 | - | $4.64 M(-8.0%) |
Mar 2022 | - | $5.04 M(-30.4%) |
Dec 2021 | $7.25 M | $7.25 M(+14.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $6.36 M(+7.8%) |
June 2021 | - | $5.90 M(-8.5%) |
Mar 2021 | - | $6.45 M(-5.9%) |
Dec 2020 | $6.86 M(-19.5%) | $6.86 M(+3.9%) |
Sept 2020 | - | $6.60 M(+28.8%) |
June 2020 | - | $5.12 M(-7.3%) |
Mar 2020 | - | $5.52 M(-35.1%) |
Dec 2019 | $8.51 M(-94.1%) | $8.51 M(-6.1%) |
Sept 2019 | - | $9.06 M(+38.9%) |
June 2019 | - | $6.52 M(-95.4%) |
Mar 2019 | - | $143.01 M(-0.2%) |
Dec 2018 | $143.29 M(+136.0%) | $143.29 M |
Dec 2017 | $60.71 M | - |
FAQ
- What is Milestone Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual total liabilities year-on-year change?
- What is Milestone Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly total liabilities year-on-year change?
What is Milestone Pharmaceuticals annual total liabilities?
The current annual total liabilities of MIST is $58.45 M
What is the all time high annual total liabilities for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual total liabilities is $143.29 M
What is Milestone Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, MIST annual total liabilities has changed by +$50.32 M (+618.56%)
What is Milestone Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of MIST is $58.69 M
What is the all time high quarterly total liabilities for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly total liabilities is $143.29 M
What is Milestone Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, MIST quarterly total liabilities has changed by +$82.00 K (+0.14%)